Stephens Inc Compugen LTD Transaction History

Stephens Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$1.68 - $2.52 $4,032 - $6,048	-2,400 Reduced 10.26%	21,000 $35,000
Q2 2023 Aug 14, 2023	BUY	$0.57 - $1.38 $227 - $552	400 Added 1.74%	23,400 $26,000
Q1 2021 May 14, 2021	BUY	$7.67 - $13.77 $176,410 - $316,710	23,000 New	23,000 $198,000
Q4 2020 Feb 10, 2021	SELL	$12.07 - $17.95 $277,610 - $412,850	-23,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$5.79 - $11.83 $40,530 - $82,810	7,000 Added 43.75%	23,000 $167,000
Q4 2019 Feb 14, 2020	BUY	$3.9 - $6.16 $62,400 - $98,560	16,000 New	16,000 $95,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.